ScienceContemporary (2016-2020)globalhigh confidence

A Moderna patent filed in 2016 contains a 'reverse complement' of a 19-nucleotide sequence found in the SARS-CoV-2 genome.

Notes on verification

Confirmed by peer-reviewed analysis (Frontiers in Virology) and further corroborated by fact-checking review; the sequence match is real but is a short, non-unique match also found in other organisms, so it does not imply intentional engineering. [tier=silver indep_score=0.867 clusters=3 claim_tier=exceptional]

Sources

A Moderna patent filed in 2016 contains a 'reverse comple… · DeepInquiry